Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Albany Molecular Research, Inc. (AMRI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Albany Molecular Research is a worldwide contract research and manufacturing organization that offers customers fully integrated drug discovery, development and manufacturing services. Through more than two decades of experience, a successful track record and locations in the U.S., Europe and … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Rexahn Pharmaceuticals, Inc. (RNN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company focused on the development and commercialization of first-in-class and market-leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. The company currently has three drug candidates in Phase II … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Cardium Therapeutics, Inc. (CXM) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Cardium Therapeutics is a health sciences and regenerative medicine company engaged in acquiring and developing products and businesses that can potentially address significant unmet medical needs and have definable pathways to commercialization, partnering or other monetization. The company’s current portfolio … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Oragenics, Inc. (ORNI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Oragenics is dedicated to becoming the global leader in probiotics for oral health for humans and companion animals, as well as novel antibiotics against infectious disease. Oragenics’ proprietary products, Evora and ProBiora, are specifically designed to enhance oral health in … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Passport Potash, Inc. (PPI) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Passport Potash is a resource company focused on the exploration and development of advanced potash properties. The company has acquired a strategic position in the Holbrook Basin with land holdings covering more than 122,000 acres. Passport has additionally formed a … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Tengion, Inc. (TNGN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Tengion is a leading clinical-stage regenerative medicine company. Tengion is currently focused on the development of its pioneering Organ Regeneration Platform to harness the body’s intrinsic regenerative pathways to produce an array of native-like organs and tissues, with the aim … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

S&W Seed Company (SANW) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

S&W Seed is a leader in the production of warm climate, high-yield alfalfa seed varieties, including varieties that are able to thrive in poor, saline soils. The company additionally offers seed cleaning and processing at its 40-acre facility in Five … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

MeetMe, Inc. (MKT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

MeetMe is the foremost social network for meeting new people in the United States; the company is additionally a market leader for social discovery. MeetMe makes the process of meeting new people enjoyable through social games and apps – monetized … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Medgenics, Inc. (MDGN) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Medgenics is engaged in developing and commercializing Biopump, a novel technology for the sustained production and delivery of therapeutic proteins utilizing patients’ own skin biopsies. Biopump is designed to treat various chronic diseases including anemia, hepatitis and hemophilia. Based on … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Lorus Therapeutics, Inc. (LOR) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Lorus Therapeutics is a biopharmaceutical company focused on the discovery, research and development of pharmaceutical products and technologies for managing cancer. The company’s aim is to capitalize on its research and preclinical, clinical and regulatory expertise through the development of … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment